Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Feb;143(3):663-72.
doi: 10.1017/S0950268814001174. Epub 2014 May 15.

HIV drug resistance in newly diagnosed adults in a rural prefecture of eastern China

Affiliations

HIV drug resistance in newly diagnosed adults in a rural prefecture of eastern China

J Hua et al. Epidemiol Infect. 2015 Feb.

Abstract

Little is known about HIV drug resistance (HIVDR) in newly diagnosed HIV-infected adults in eastern China where the HIV epidemic is spreading predominantly through sexual contact. During 2008-2011, newly HIV-diagnosed adults in Taizhou prefecture, Zhejiang province in eastern China were examined for HIVDR by amplifying and sequencing the HIV-1 pol gene. Of 447 genotyped participants, 53·7% were infected with CRF01_AE, 20·1% with CRF07_BC, 12·5% with subtype B, and 11·6% with CRF08_BC. Most of the participants had one or more minor genetic mutations in the pol gene that are associated with HIVDR. Twelve (2·7%) participants met the standard guidelines of having low to high HIVDR, suggesting that the prevalence of HIVDR in newly HIV-diagnosed adults was low in the study area and current antiretroviral therapy (ART) regimens are likely to remain effective. However, given high frequency of minor HIVDR in HIV patients and the scaling up of ART programmes in China, larger HIVDR surveillance programmes are needed.

Keywords: Antiretroviral therapy (ART); China; HIV drug resistance; transmission.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

Cited by

References

    1. Michaels SH, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 1998; 339: 405–406. - PubMed
    1. Braitstein P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367: 817–824. - PubMed
    1. Zhang F, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Annals of Internal Medicine 2009; 151: 241–252. - PubMed
    1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372: 293–299. - PMC - PubMed
    1. Ministry of Health, People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2011. Estimates for the HIV/AIDS epidemic in China. Beijing: Ministry of Health of China, 2012.

Publication types

MeSH terms

Substances